3D Bio-Printing Market Outlook 2024: Global Opportunity and Demand Analysis, Market Forecast, 2016-2024

Global 3D Bioprinting Market

Market Overview

3D Bioprinting is the process of constructing or creating 3D biological structures using live cells. 3D printing technology is used in process for creating tissue structures and live cells. These structures and technology are used for various applications in pharmaceutical or healthcare and for research. 3D Bioprinting revolutionized the development and innovation of new drugs which will impel the growth of this revolutionary technology in coming years. Pressure-assisted based technology, inkjet based technology, and the laser assisted technologies are the major technologies used for 3D Bioprinting. The 3D Bioprinting technology has different applications such as tissue and organ regeneration, cell culture and pharmaceutical development. Being in nascent form the market is not very much progressive but regular innovation and its vast usage shows its vast potential and estimated to witness significant growth in nearby future. Innovation and huge investments by the research laboratories and academic institutions in order to achieve better processes and to increase the area of its implementation are the key factors that will boost the demand for 3D Bioprinting in nearby future. For instance, San Francisco based Prellis Biologics has raised USD 1.8 million for the advancement of 3D Bioprinting technology to develop micro-vascular human organ printing. The company is focusing on 3D printing insulin producing tissues.

Market Segmentation

• By Technology

• Inkjet Based Bio Printing
• Extrusion Based Bio Printing
• Laser Based Bio Printing

• By Applications

• Pharmaceuticals
• Tissue and Organ Regeneration
• Bones
• 3D Cell Culture
• other

• By Geography

• North America (US, Canada) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
• Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
• Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
• Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
• Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
• Rest of the World {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}

Growth Drivers and Challenges

3D bio printers are being used in regeneration of organs and tissues to carry out the research of various drugs and processes in pharmaceutical industry, cosmetics industries and in healthcare sector providing growth opportunities to the 3D Bioprinting Market. Strategic alliances of 3D Bioprinting market players with the pharmaceutical and cosmetic companies will provide the strategic edge over the competitors and also boosts the market growth. For instance, in 2015 alliance of Organavo with the L'Oreal to research and develop 3d printed skin tissues for research of new cosmetics have marked the presence of 3D Bioprinting technology in cosmetic industry. Similarly, Johnson & Johnson is setting up and making investments in 3D printed bones to fix deformities and injuries. According to World Health organization (WHO) more than 119,873 organs were transplanted which is increasing by 1.81% annually. Shortage of organs and rising need for transplants has significantly bolstered the demand for 3D bio-printed organs to overcome the shortage of organs for transplants.

However, being in its nascent stage huge investments and high cost of devices hinders the growth of 3d bio printing market. But, once 3D Bioprinting of human tissues and organs become commercially feasible, patients will have access to these organs, printed using the size and organic structure they need. As healthcare cost drops, these innovation will play an important role for both emerging and developed economies.

Market Size and Forecast

The global 3D Bioprinting market accounted for USD 0.460 billion in 2016 and expected to reach USD 1.3 billion by the end of forecast period i.e. 2024. Further the market is anticipated to expand at compound annual growth rate of 13.8% over the forecast period i.e. 2016-2024. Where the 3D Bioprinters Market size is set to reach USD 1.24 billion by 2024, at a CAGR of 24% over the forecast years.

Geographically, North America accounted for the highest revenue share of 30% in global 3D Bioprinting market owing to government initiatives to improve healthcare sector and extensive research activities conducted within the region. Further, the North America 3D Bioprinting is projected to grow at a CAGR of 9.6% over the forecast period. Asia-Pacific region is anticipated to witness considerable growth owing to increasing expenditure over healthcare sector and rapid adoption of advanced technologies in countries such as Singapore, South Korea, China and Japan. Furthermore, rising foreign investment within the region in healthcare sector is expected to impel the expansion of 3D Bioprinting technology in the region over the forecast period.

Key Market Players

• Organavo
  • Synopsis
  • Business strategy
  • Product Portfolio
  • SWOT Analysis
• BioBots
• Cellink
• Poietis
• EnvisionTec Gmbh
• Nano3D Biosciences Inc.
• Cyfuse Biomedical
• 3D Biotek LLC
• RegenHU ltd.
• Insphero
• GeSim

Scope Background

Market Synopsis

Market Segmentation

Global 3d Bioprinting market is segmented as follows:

• By Technology Type (Market Size, Demand Analysis and Growth Analysis)
• By Application Type (Market Size, Demand Analysis and Growth Analysis)

Global 3D Bioprinting Market Report covered insights of below mentioned regions:

• North America (U.S., Canada) {Market Size, Growth Analysis and Opportunity Analysis}
• Latin America (Argentina, Mexico, Brazil and Rest of Latin America) {Market Size, Growth Analysis and Opportunity Analysis}
• Europe (Germany, Italy, Spain, France, The U.K., Netherlands, Sweden, Hungary, Russia, Poland, Rest of Europe) {Market Size, Growth Analysis and Opportunity Analysis}
• Asia-Pacific (China, India, Singapore, Japan, Australia, New Zealand, South Korea and Rest of Asia Pacific) {Market Size, Growth Analysis and Opportunity Analysis}
• Middle East and North Africa (MENA) {Market Size, Growth Analysis and Opportunity Analysis}
• Rest of World {Market Size, Growth Analysis and Opportunity Analysis}

Market Dynamics: Growth Drivers, Restraints and Opportunities

• Risk Factors
• Regional Variations
• Recent Trends and Developments

Key Market Players

• Synopsis
• Business Strategy
• Product Portfolio
• SWOT Analysis

Porter’s Five Force Model

Market Landscape: Competition and Beyond

Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem

Expert Analysis

Concluding Remark